glutathione supplement cancer risk Frontiers Antioxidants Accelerate the Growth and

doi: 10.3389/fphar.2026.1786693 Received 13 January 2026 Revised 24 February 2026 Accepted 06 March 2026 Published 01 April 2026 Volume 17 - 2026 Edited by Galina Sudina, Lomonosov Moscow State University, Russia Reviewed by Patricia Silva Santos Ribeiro, Erasmus Medical Center, Netherlands Ahmi z, Sleyman Demirel University, Trkiye Updates Copyright 2026 Chen, Li and He

Critical Safety Considerations BPC-157 has not received approval from Health Canada or the US FDA for human therapeutic use

10.1152/ajpendo.00048.2011 [DOI] [PubMed] [Google Scholar] Chen, S

10 In the study by Jung et al, 11 no adverse effects were reported after 12 weeks of use among the 24 participants

These principles of careful handling and administration are critical across the board, whether you're researching BPC-157, TB-500, or any of the other advanced compounds in our full research collection